Jiangxi Sanxin Medtec Co Ltd Total Assets
Jiangxi Sanxin Medtec Co Ltd total assets. Based on the latest financial reports, Jiangxi Sanxin Medtec Co Ltd (300453) holds total assets worth CN¥2.47 Billion CNY (≈ $360.73 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 300453 company net worth for the company's overall valuation and market capitalisation.
Total Assets of Jiangxi Sanxin Medtec Co Ltd (2011–2025)
Total assets of Jiangxi Sanxin Medtec Co Ltd from 2011 to 2025. This chart illustrates how Jiangxi Sanxin Medtec Co Ltd's total assets have evolved over time, based on quarterly financial data. See 300453 share price today for real-time trading data and today's change.
Jiangxi Sanxin Medtec Co Ltd - Asset Composition Analysis
Jiangxi Sanxin Medtec Co Ltd Total Assets Breakdown (December 2025)
Jiangxi Sanxin Medtec Co Ltd total assets breakdown as of December 2025. Jiangxi Sanxin Medtec Co Ltd's total assets of CN¥2.47 Billion consist of 38.1% current assets and 61.9% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 17.8% |
| Accounts Receivable | CN¥76.65 Million | 3.2% |
| Inventory | CN¥199.97 Million | 8.2% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥154.09 Million | 6.3% |
| Goodwill | CN¥79.58 Million | 3.3% |
Asset Composition Trend (2011–2025)
This chart illustrates how Jiangxi Sanxin Medtec Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Jiangxi Sanxin Medtec Co Ltd current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Jiangxi Sanxin Medtec Co Ltd's current assets represent 38.1% of total assets in 2025, a decrease from 45.6% in 2011.
- Cash Position: Cash and equivalents constituted 17.8% of total assets in 2025, up from 13.1% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 5.0% in 2011.
- Asset Diversification: The largest asset category is inventory at 8.2% of total assets.
Jiangxi Sanxin Medtec Co Ltd Competitors by Total Assets
Key competitors of Jiangxi Sanxin Medtec Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Autek China Inc
SHE:300595
|
China | CN¥6.40 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Crossject
PA:ALCJ
|
France | €30.43 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.39 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
Jiangxi Sanxin Medtec Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.42 | 1.47 | 1.44 |
| Quick Ratio | 1.01 | 1.11 | 1.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥268.33 Million | CN¥252.91 Million | CN¥151.33 Million |
Jiangxi Sanxin Medtec Co Ltd - Advanced Valuation Insights
This section examines the relationship between Jiangxi Sanxin Medtec Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.19 |
| Latest Market Cap to Assets Ratio | 0.30 |
| Asset Growth Rate (YoY) | 9.3% |
| Total Assets | CN¥2.43 Billion |
| Market Capitalization | $730.36 Million USD |
Valuation Analysis
Below Book Valuation: The market values Jiangxi Sanxin Medtec Co Ltd's assets below their book value (0.30x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Jiangxi Sanxin Medtec Co Ltd's assets grew by 9.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Jiangxi Sanxin Medtec Co Ltd (2011–2025)
The table below shows the annual total assets of Jiangxi Sanxin Medtec Co Ltd from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥2.43 Billion ≈ $355.42 Million |
+9.28% |
| 2024-12-31 | CN¥2.22 Billion ≈ $325.25 Million |
+9.45% |
| 2023-12-31 | CN¥2.03 Billion ≈ $297.17 Million |
+13.67% |
| 2022-12-31 | CN¥1.79 Billion ≈ $261.43 Million |
+27.06% |
| 2021-12-31 | CN¥1.41 Billion ≈ $205.75 Million |
+12.96% |
| 2020-12-31 | CN¥1.24 Billion ≈ $182.15 Million |
+8.65% |
| 2019-12-31 | CN¥1.15 Billion ≈ $167.65 Million |
+38.46% |
| 2018-12-31 | CN¥827.43 Million ≈ $121.08 Million |
+23.40% |
| 2017-12-31 | CN¥670.54 Million ≈ $98.12 Million |
+7.24% |
| 2016-12-31 | CN¥625.26 Million ≈ $91.50 Million |
+5.57% |
| 2015-12-31 | CN¥592.28 Million ≈ $86.67 Million |
+55.30% |
| 2014-12-31 | CN¥381.37 Million ≈ $55.81 Million |
+15.67% |
| 2013-12-31 | CN¥329.71 Million ≈ $48.25 Million |
+23.43% |
| 2012-12-31 | CN¥267.12 Million ≈ $39.09 Million |
+33.58% |
| 2011-12-31 | CN¥199.96 Million ≈ $29.26 Million |
-- |
About Jiangxi Sanxin Medtec Co Ltd
Jiangxi Sanxin Medtec Co.,Ltd. engages in the research and development, manufacture, sale, and service of medical devices. It offers infusion and cardiothoracic surgery products and blood purification products, such as central concentrate delivery systems, disposable biological protein glue dispensers, disposable blood dialyzers, hemodialysis filters, hemodialysis concentrates and powders, contin… Read more